Atria Investments’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$808K Buy
17,098
+2,703
+19% +$139K 0.01% 1231
2026
Q1
$853K Sell
14,395
-780
-5% -$50.6K 0.01% 1148
2025
Q4
$936K Sell
15,175
-3,674
-19% -$225K 0.01% 1106
2025
Q3
$1.18M Buy
18,849
+1,861
+11% +$130K 0.01% 967
2025
Q2
$1.36M Buy
16,988
+2,186
+15% +$183K 0.02% 901
2025
Q1
$1.27M Sell
14,802
-7,451
-33% -$611K 0.02% 904
2024
Q4
$1.74M Buy
22,253
+4,570
+26% +$355K 0.02% 737
2024
Q3
$1.27M Sell
17,683
-94
-0.5% -$6.66K 0.02% 861
2024
Q2
$1.22M Buy
17,777
+599
+3% +$40.6K 0.02% 833
2024
Q1
$1.25M Buy
+17,178
New +$1.15M 0.02% 856

Other funds holding PBH

Atria Investments's PBH Position: Q2 2026 in Review

Atria Investments increased its Prestige Consumer Healthcare (PBH) stake by 19% in Q2 2026, buying an estimated $139K and bringing the position to 17,098 shares worth $808K. The position accounts for 0.01% of the portfolio, ranked #1231.

Atria Investments first reported a position in PBH in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.74M in Q4 2024. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Atria Investments held 17,098 shares of Prestige Consumer Healthcare worth $808K as of Q2 2026.
  • Atria Investments bought 2,703 Prestige Consumer Healthcare shares in Q2 2026, an estimated $139K.
  • Prestige Consumer Healthcare made up 0.01% of Atria Investments's portfolio in Q2 2026, its #1231 holding.
  • Atria Investments first reported a position in Prestige Consumer Healthcare in Q1 2024 and has held it in 10 quarters since.
  • Atria Investments's Prestige Consumer Healthcare position peaked at $1.74M in Q4 2024.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.